Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

155results about How to "Prevent or" patented technology

Vapor hydration of a hydrophilic catheter in a package

ActiveUS20060163097A1Little and no possibility of liquid spillageEasy to handleDispensing apparatusDiagnosticsHydrophilic coatingBiological activation
A vapor hydrated packaged catheter assembly and method of manufacturing and distributing same includes a gas impermeable package housing a catheter within a catheter-receiving cavity. The catheter assembly has a hydrophilic coating applied to at least a portion of the outer surface of a catheter tube or shaft which may be surrounded by a sleeve to provide a no-touch, sure grip feature. The catheter assembly is disposed within the catheter receiving cavity of the package together with a limited amount of a vapor donating liquid provided as a source of vapor to activate the hydrophilic coating. The amount of vapor donating liquid is less than the amount that would otherwise be sufficient to cause a spill hazard. It may be loose liquid as a desired percentage of the volume of a tube-receiving portion of the catheter receiving cavity of the package, or it may be contained in a liquid sequestering element. The activation of at least some of the hydrophilic coating occurs solely by reason of exposure of the outer surface of the catheter to a vapor produced by the vapor donating liquid. The distribution of the catheter following manufacture is delayed for a time sufficient to permit the vapor to complete hydration of the entire hydrophilic coating on the surface.
Owner:HOLLISTER INCORPORAED

Software distribution method and system with automatic prerequisite installation

InactiveUS20060048145A1Reduce needIncrease reliability and performanceProgram loading/initiatingMemory systemsPreconditionSoftware
A software distribution method (300) is proposed. The solution of the invention relates to the deployment (from a source host to selected endpoints) of main packages that require one or more prerequisite packages. In this case, the source host builds (304-326) and transmits (330-332) a multi-segment distribution structure that embeds the main package and any prerequisite package that is not available on at least one of the endpoints. Each endpoint receiving the distribution structure only installs (336-360) the prerequisite packages that are not available on the endpoint. The main package can then be installed (362-366) correctly (with the required configuration of the endpoint)
Owner:IBM CORP +1

Removable vena cava filter having primary struts for enhanced retrieval and delivery

ActiveUS20050267513A1Simple deliverySimplified deliverySurgeryDilatorsEngineeringBlood vessel
A removable filter having a collapsed state and an expanded state for capturing thrombi in a blood vessel is disclosed. The filter comprises a plurality of primary struts and a plurality of secondary struts. Each primary strut in the expanded state extends from a primary strut first end to an anchoring hook. Each primary strut extends arcuately along a longitudinal axis and linearly radially. The plurality of primary strut first ends are attached together along the longitudinal axis. Each secondary strut in the expanded state extends from a secondary strut first end to a free end. Each secondary strut extends arcuately along the longitudinal axis and linearly radially. The plurality of secondary struts are attached together along the longitudinal axis. The plurality of secondary struts centralize the filter in the expanded state in the blood vessel.
Owner:COOK MEDICAL TECH LLC

Magnet-shunted systems and methods

InactiveUS20070046408A1Eliminate wavesMinimize the path and/or shunt membersActive shieldingMagnetsPhysicsMagnet
The present invention relates to a magnet-shunted system for shielding a target from magnetic fields and waves. More particularly, the present invention relates to a magnet system including a path member and a magnet member having a magnet at least partially shielded by a magnetically permeable shunt member. The path member forms a path through which the extrinsic magnetic fields and waves bypass the target, the magnet member serves as a termination point for the magnetic fields or waves, and the shunt member defines another path through which primary magnetic fields generated by the magnet member are confined very close to the shunt and / or magnet members. The present invention relates to various methods of forming the termination point, eliminating the extrinsic magnetic fields or waves by the magnet, and disposing the magnet member into the path member. The present invention also relates to various processes for providing such a magnet-shunted system including the foregoing magnet and path members along with the optional shunt member.
Owner:SHIM YOUNGTACK

Affinity membrane for capture of a target biomolecule and formation thereof by site-directed immobilization of a capture biomolecule

Compositions and methods are taught for directing the orientation of an immobilized capture biomolecule on a hydrophobic membrane. The method comprises layering at least one tie layer on a hydrophobic membrane, adding an amine functional layer on top of at least one tie layer; and attaching an alignment biomolecule to the amine functional layer. The alignment biomolecule has the ability to either capture a target biomolecule itself and thus be considered a capture biomolecule, or bind and orient the immobilized capture biomolecule so as to maximize the binding activity of the immobilized capture biomolecule. In one embodiment, a nickel-coordinated amine functional layer binds with a histidine-tagged alignment biomolecule. In another embodiment, an amine functional layer reacts, via tyrosinase catalysis, with a tyrosine residue in an alignment biomolecule.
Owner:MARYLAND UNIV OF +1

Reprogramming of Differentiated Progenitor or Somatic Cells Using Homologous Recombination

The present invention provides methods and compositions for reprogramming somatic cells to a more primitive state, such as induced pluripotent stem cells, using homologous recombination. The induced pluripotent stem cells generated by the methods of the present invention are useful in a variety of therapeutic applications in the treatment and prevention of diseases and disorders.
Owner:NEVADA CANCER INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products